Document Type : Case Report


International Academy for Medical Sciences, The Regenerate Clinics India, Hyderabad, Telangana, India.


Cancer: An Electrically Mediated Dysfunction in the Body

Graphical Abstract

Cancer: An Electrically Mediated Dysfunction in the Body


Main Subjects

1.            Chernet BT, Levin M. Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model. Dis Model Mech. 2013; 6(3): 595-607. [crossref]


2.            Nordenstrom BEW. Biologically closed electrical circuits: clinical, experimental and theoretical evidence for an additional circulatory system. Stockholm: Nordic Medical Publications. 1983. 

3.            Chouhan RS. Bioelectrography in detection of cancer. Int Uro-Gyneacol Assoc Meet Ljubljana. 1986. 

4.            Kadir LA, Stacey M, Barrett-Jolly R. Emerging roles of the membrane potential: Action beyond the action potential. Front Physiol. 2018; 9: 1661. [crossref]

5.            Cone CD Jr. Unified theory on the basic mechanism of normal mitotic control and oncogenesis. J Theor Biol. 1971; 30(1): 151-181. [crossref]

6.            Binggeli R, Weinstein RC. Membrane potentials and sodium channels: hypotheses for growth regulation and cancer formation based on changes in sodium channels and gap junctions. J Theor Biol. 1986; 123(4): 377-401. [crossref]

7.            Cure JC. Cancer an electrical phenomenon. Resonant. 1991; 1(1).

8.            Cure JC. On the electrical characteristics of cancer. The Second International Congress of Electrochemical Treatment of Cancer. 1995; Jupiter, Florida.

9.            Dargel R. Lipid peroxidation: A common pathogenetic mechanism? Exp Toxicol Pathol. 1992; 44(4): 169-181. [crossref]

10.          Skrzydlewska E, Sulkowski S, Koda M. Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol. 2005; 11(3): 403-406. [crossref]

11.          Nieper HA. Dr. Nieper’s revolution in technology, medicine and society. Oldenburg, Germany: MIT Verlag; 1985.

12.          Cone CD Jr. Variation of the transmembrane potential level as a basic mechanism of mitosis control. Oncol. 1970; 24(6): 438-470.


13.          Cope FW. A medical application of the ling association-induction hypothesis: the high potassium, low sodium diet of the Gerson cancer therapy. Physiol Chem Phys. 1978; 10(5): 465-468. [PMID]

14.          Haltiwanger SG. Clinical use of mineral transporters and their effects on cell membrane capacitance. Second International Congress of BioEnergetic Medicine. Instit Quant Mol Med. 1998; Melbourne, FL.

15.          Haltiwanger SG. The electrical properties of cancer cells. Rife 2003 International Health Conference. 2003; Seattle, WA:

16.          Cho YS, Resasco D, Schaff J, Slepchenko B. Electrodiffusion of ions inside living cells. IMA J Appl Math. 1999; 62(3): 207-226. [crossref]

17.          Foster KR, Schepps JL. Dielectric properties of tumor and normal tissues at radio through microwave frequencies. J Microwave Power. 1981; 16(2): 107-119. [PMID]

18.          Burr HS, Strong LC, Smith GM. Bio-electric correlates of methylcolanthrene-induced tumors in mice. Yale J Biol Med. 1938; 10(6): 539-544. [PMID]

19.          Burr HS. Biologic organization and the cancer problem. Yale J Biol Med. 1940; 12(3): 277-282. [PMID]

20.          Chouhan RS, Pagadala R. Bioelectrography in early detection of cancer. World Conference of Obstetrics and Gynaecology, Proceedings of FIGO-91, Singapore, 1991.

21.          Riedl S, Zweytick D, Lohner K. Membrane-active host defense peptides - challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids. 2011; 164(8): 766-781. [crossref]

22.          Van Rinsum J, Smets LA, Van Rooy H, Van Den Eunden DH. Specific inhibition of human natural killer cell-mediated cytotoxicity by sialic acid and sialo-oligosaccharides. Int J Canc. 1986; 38(6): 915-922. [crossref]

23.          Acevedo H, Gonzalez N, Moss R. Trophoblastic hormones and cancer: A breakthrough in treatment? Comprehensive Cancer Care Conference. 1998; Session 205: June 13.